High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients.
about
Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and DifferencesCardio-renal syndromeAngiotensin-II-induced Muscle Wasting is Mediated by 25-Hydroxycholesterol via GSK3β Signaling Pathway.Low-level laser therapy improves the inflammatory profile of rats with heart failure.Pathophysiology and treatment of inflammatory anorexia in chronic disease.Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circleCachexia in malaria and heart failure: therapeutic considerations in clinical practice.Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status.Cardiac cachexia.Maximal oxygen uptake and exercise tolerance are improved in rats with heart failure subjected to low-level laser therapy associated with resistance training.Cardiac cachexia at a glance.TNF signals via neuronal-type nitric oxide synthase and reactive oxygen species to depress specific force of skeletal muscle.How can we cure a heart "in flame"? A translational view on inflammation in heart failure.Chronic inflammation is associated with low physical function in older adults across multiple comorbidities.Weight change after myocardial infarction--the Enhancing Recovery in Coronary Heart Disease patients (ENRICHD) experience.Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II.Beyond atrophy: redox mechanisms of muscle dysfunction in chronic inflammatory disease.Intensive care unit-acquired weakness: clinical phenotypes and molecular mechanisms.Exercise training decreases NADPH oxidase activity and restores skeletal muscle mass in heart failure rats.Correlation of serum biomarkers in adults with single ventricles with strain and strain rate using 2D speckle tracking.Handgrip strength as a predictor of prognosis in Japanese patients with congestive heart failure.Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis.
P2860
Q26767412-561398AF-35B5-4AD9-AE4B-1E70DD846DEBQ28067064-9CB55C5D-9B9B-4CD2-B927-F9723FDFF8C9Q33809770-111304BE-2FAC-4391-8590-466F1EBEA9EBQ34398672-CA065974-ECC1-4A6C-A849-2FC78D86750CQ34697279-C5C64CAF-0B27-4029-86DF-987DB447A5E7Q35223968-E9C1D031-70B8-441A-B2DA-B15BC6EF14E5Q35520657-FD61FEFC-4427-4B90-B6E4-5D56C5DDDA30Q35536202-5BD257E1-F936-40EF-B0DC-07B28001C637Q35537056-552F75C5-61EC-477C-807B-E9382A6EE89AQ35932382-A1088E6A-6F91-479A-8ACD-7075CF3DE030Q36196235-484077DC-B0A4-4090-87E2-24CEFF66FAA5Q36836579-8D1C1488-30DB-4328-B272-F874F04ECEF0Q36924162-09945DE0-B41E-4B31-8D5B-196E7407F3C9Q37004826-3528CDFC-C024-4C14-B6AF-85039F4D5E73Q37132103-1B93EB54-BAFB-488B-864A-20E343E4FBEEQ37365552-A415A206-12F3-451C-B111-DF0BAB9AC0D8Q37827023-E461E5D0-3334-4B04-98C7-B894A6924299Q37841941-54728649-E83C-4B2E-BAB9-5F1F824EBC57Q38064396-CC1B0EB7-FC8F-4B6E-9037-08E26ADDBE2BQ39011225-1582917D-947A-4EF5-A33E-40A19A620033Q39535023-7BBD55EE-6AB0-4C2B-A22F-B4B9E2C01010Q40000295-C7CB81A1-3450-4816-88A7-30C7E418EBDDQ45077756-F0D616C3-CC7D-4C8A-A6DF-8C932E9F2268
P2860
High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
High tumour necrosis factor-al ...... hronic heart failure patients.
@en
High tumour necrosis factor-al ...... hronic heart failure patients.
@nl
type
label
High tumour necrosis factor-al ...... hronic heart failure patients.
@en
High tumour necrosis factor-al ...... hronic heart failure patients.
@nl
prefLabel
High tumour necrosis factor-al ...... hronic heart failure patients.
@en
High tumour necrosis factor-al ...... hronic heart failure patients.
@nl
P2093
P356
P1433
P1476
High tumour necrosis factor-al ...... chronic heart failure patients
@en
P2093
Al-Nasser FO
Rauchhaus M
P356
10.1006/CYTO.2001.0918
P577
2001-07-01T00:00:00Z